Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| IMNN | 8-K | bearish | 5/10 | Imunon (IMNN) exchanged $1.2M of its secured promissory A-1 Note held by Streeterville Capital for 120 shares of newly c | Sep 29, 2026 |
| SURG | 8-K | bearish | 7/10 | SurgePays received a second 180-day compliance period from Nasdaq, extending the deadline to March 22, 2027, to regain t | Sep 29, 2026 |
| ALLR | 8-K | neutral | 2/10 | Allarity Therapeutics announced the expansion of its in-house medical laboratory to include proteomics and cell line res | Sep 29, 2026 |
| BLMN | 8-K | neutral | 3/10 | Bloomin' Brands amended and restated its $1.2 billion revolving credit facility, extending the maturity to September 25, | Sep 29, 2026 |
| ATOS | 8-K | neutral | 4/10 | Atossa Therapeutics announced a plan to issue one contingent value right (CVR) per share of common stock, entitling hold | Sep 29, 2026 |
| UNCY | 8-K | bullish | 7/10 | Unicycive Therapeutics resubmitted its NDA for oxylanthanum carbonate (OLC) to the FDA on September 29, 2026, using a ne | Sep 29, 2026 |
| SSTI | 8-K | bullish | 7/10 | SoundThinking (SSTI) has entered into a definitive agreement to be acquired by affiliates of Transom Capital Group in a | Sep 29, 2026 |
| RNAC | 8-K | bullish | 6/10 | Cartesian Therapeutics announced additional positive retreatment data for its lead CAR-T candidate, Descartes-08, in mya | Sep 29, 2026 |
| IVVD | 8-K | bullish | 7/10 | Invivyd announced positive topline results from the LIBERTY Phase 3 study, showing VYD2311 met all primary and secondary | Sep 29, 2026 |
| AQST | 8-K | neutral | 2/10 | Aquestive Therapeutics appointed Richard J. Daly to its Board of Directors, effective October 14, 2026, expanding the bo | Sep 29, 2026 |
| JELD | 8-K | mixed | 6/10 | JELD-WEN entered into a commitment letter with holders of ~94.5% of its 2027 Notes and ~72.2% of its 2028 Term Loans to | Sep 29, 2026 |
| IOVA | 8-K | bullish | 6/10 | Iovance Biotherapeutics raised its full year 2026 total revenue guidance to $410–$420 million, up from the prior range o | Sep 29, 2026 |
| SHW | 8-K | neutral | 3/10 | Sherwin-Williams entered into a new $750 million 364-day senior unsecured term loan credit agreement, refinancing and te | Sep 29, 2026 |
| FLWS | 8-K | bullish | 6/10 | 1-800-FLOWERS.COM, Inc. (FLWS) has entered into a definitive asset purchase agreement to sell its PersonalizationMall.co | Sep 29, 2026 |
| ALT | 8-K | neutral | 2/10 | Altimmune appointed Richard Menziuso as Vice President, Global Controller and Principal Accounting Officer, effective Se | Sep 29, 2026 |
| BYSI | 8-K | mixed | 6/10 | BeyondSpring entered into a definitive agreement to sell its wholly owned subsidiary (which indirectly holds a 57.97% st | Sep 29, 2026 |
| ALDX | 8-K | bullish | 7/10 | Aldeyra Therapeutics announced its intent to submit a Formal Dispute Resolution Request (FDRR) to the FDA's Office of Ne | Sep 29, 2026 |
| DAIC | 8-K | neutral | 5/10 | CID HoldCo (DAIC) entered into a Securities Purchase Agreement to acquire 100% of Envoy Technologies from BladeRanger Lt | Sep 29, 2026 |
| KMX | 8-K | bullish | 7/10 | CarMax reported Q2 FY2027 EPS of $1.16, well above the $0.73 consensus, on revenue of $7.88B versus $7.03B consensus. Co | Sep 29, 2026 |
| IMMX | 8-K | bullish | 7/10 | Immix Biopharma reported an interim update from its Phase 2 NEXICART-2 trial showing an 89% (40/45) complete response ra | Sep 29, 2026 |
| AUB | 8-K | neutral | 2/10 | Atlantic Union Bankshares filed an 8-K announcing the date of its Q3 2026 earnings release and conference call, schedule | Sep 29, 2026 |
| TE | 8-K | bearish | 6/10 | T1 Energy issued an additional $50.0 million in 4.75% Convertible Senior Notes due 2031 to an existing shareholder via a | Sep 29, 2026 |
| ALZN | 8-K | neutral | 3/10 | Alzamend Neuro filed an 8-K to disclose a presentation at the ISMRT Conference on September 29, 2026, by the principal i | Sep 29, 2026 |
| WLK | 8-K | bearish | 6/10 | Westlake announced the closure of its Cologne, Germany PVC plant (165,000 metric tons annual capacity) due to challengin | Sep 29, 2026 |
| LBSR | 8-K | bearish | 5/10 | Liberty Star Uranium & Metals Corp. issued a $95,700 convertible promissory note to Monroe Street Capital Partners LP, r | Sep 29, 2026 |
| SWRD | 8-K | mixed | 6/10 | Stewards, Inc. (SWRD) completed the acquisition of Envy Pompano Beach, a mixed-use multifamily and marina property in Po | Sep 29, 2026 |
| UEC | 8-K | mixed | 6/10 | Uranium Energy Corp reported fiscal 2026 full-year results, highlighting a transformative year as it became a multi-mine | Sep 29, 2026 |
| SMMT | 8-K | bullish | 8/10 | Summit Therapeutics entered into a securities purchase agreement with AstraZeneca Holdings B.V. for a $2.0 billion priva | Sep 28, 2026 |
| FWAC | 8-K | neutral | 5/10 | Futurewave Acquisition Corp (FWAC) entered into a definitive merger agreement to acquire Olympian Group Inc., an integra | Sep 28, 2026 |
| KFY | 8-K | neutral | 3/10 | Korn Ferry stockholders approved the Amended and Restated 2022 Stock Incentive Plan at the 2026 Annual Meeting, increasi | Sep 28, 2026 |